Gainers

• Intelligent Bio Solutions (NASDAQ:INBS) shares moved upwards by 43.7% to $11.34 during Monday's regular session. The company's market cap stands at $7.5 million.
• Passage Bio (NASDAQ:PASG) shares moved upwards by 41.57% to $16.55. The market value of their outstanding shares is at $37.1 million.
• Regencell Bioscience (NASDAQ:RGC) stock increased by 37.92% to $28.33. The market value of their outstanding shares is at $10.1 billion.
• Redhill Biopharma (NASDAQ:RDHL) stock increased by 25.72% to $1.29. The company's market cap stands at $3.4 million.
• Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares moved upwards by 25.62% to $0.1.
• Kazia Therapeutics (NASDAQ:KZIA) stock moved upwards by 20.99% to $6.05. The market value of their outstanding shares is at $56.6 million.

Losers

• Zenas BioPharma (NASDAQ:ZBIO) shares fell 53.5% to $16.04 during Monday's regular session. The company's market cap stands at $1.8 billion.
• Outlook Therapeutics (NASDAQ:OTLK) stock fell 21.22% to $0.52. The company's market cap stands at $42.3 million.
• Salarius Pharmaceuticals (NASDAQ:SLRX) shares fell 19.91% to $0.52. The company's market cap stands at $3.8 million.
• Palvella Therapeutics (NASDAQ:PVLA) shares decreased by 14.93% to $85.31. The company's market cap stands at $1.1 billion.
• Profusa (NASDAQ:PFSA) shares declined by 14.41% to $0.09. The company's market cap stands at $8.6 million.
• Accendra Health, Inc. Common Stock (NYSE:ACH) stock fell 12.94% to $2.02. The company's market cap stands at $179.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.